If the 8q24.21 CLL locus influences risk through a similar cis-effect on differential MYC expression, the association is intriguing because MYC is a direct target of IRF4 in activated B-cells. The gene discussed is IRF4; the disease is B-cell chronic lymphocytic leukemia.